Viewing nowCombinationTelmisartan 40/2.5 mg (Telmisartan, Amlodipine Besylate Hydrate)
Telmisartan 40mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.

MFDS item code 201302981 · Approved 2013.01.31 · Insurance code 643306520
Treatment of essential hypertension not controlled by monotherapy
Essential hypertension is a condition where blood pressure remains persistently elevated, placing stress on the heart and blood vessels. Telmisartan and Amlodipine (Amlodipine) are medications that lower blood pressure, with each acting to either relax blood vessels or reduce vascular resistance to control blood pressure. When these medications are used alone yet blood pressure is not adequately controlled, combination therapy may be required for more effective treatment. Thus, the treatment applicable to patients with essential hypertension involves the combined use of Telmisartan and Amlodipine to achieve appropriate blood pressure management. This treatment helps to steadily lower blood pressure and reduce the risk of cardiovascular diseases. Therefore, it is used in the control of blood pressure for patients with essential hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the doses of the individual components (telmisartan or S-amlodipine (amlodipine)) be adjusted. However, if blood pressure is not adequately controlled with an individual component, switching directly to this medicine may be considered as follows: - 40/2.5 milligrams: For patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or telmisartan 40 milligrams. - 80/2.5 milligrams: For patients whose blood pressure is not adequately controlled with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams). - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with telmisartan 40 milligrams or 80 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with telmisartan 80 milligrams or this medicine 40/5 milligrams. Patients taking telmisartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ◦ Patients with renal impairment: No dose adjustment is needed for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended that treatment be started at a low dose and the dose increased gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section '3. Patients in whom this medicine should be used with caution'). For elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
◦ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can pose serious risks to the fetus, especially during the second and third trimesters of pregnancy, and should not be used during pregnancy. If pregnancy is confirmed, the use of this medication should be discontinued as soon as possible. This medication should not be administered to patients with certain conditions, such as severe liver impairment, severe hypotension, or unstable heart failure post-acute myocardial infarction. Also, women of childbearing potential or nursing mothers should not take this medication. Patients with primary aldosteronism, aortic stenosis, mitral stenosis, or obstructive hypertrophic cardiomyopathy require special caution when using this medication. Patients with liver impairment may be affected in the metabolism and elimination of this drug; therefore, dosage adjustments may be necessary. While taking this medication, various side effects like dizziness, headache, edema, palpitations, and nausea may occur; if symptoms are severe, consultation with a doctor should be sought. Hypotension may occur; thus, patients with inadequate body fluid or electrolytes should correct their condition before administration and carefully monitor blood pressure during the treatment. As potassium levels can increase in the blood, patients at risk of hyperkalemia should have their potassium levels checked through regular blood tests. Patients with decreased kidney function should also monitor for changes in renal function while taking this medicine and adjust the dosage as needed. This drug may interact with other medications, so caution is necessary when taken with digoxin, lithium, non-steroidal anti-inflammatory drugs, simvastatin, etc. Elderly patients may be more sensitive to this medication, so it is advisable to start with a lower dose and gradually increase it upon initiation. In the case of overdose, symptoms such as hypotension, dizziness, and cardiac abnormalities may appear; therefore, immediate medical attention is needed. This medication is not recommended for children as its safety and efficacy have not been sufficiently established.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from entering and kept at a temperature between 1 to 30 degrees Celsius. Proper storage will maintain the efficacy of the medication and ensure safe use.
Light yellow - light blue oval tablets with two layers
30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 80mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 40mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationTelmisartan 80mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Telmisartan 80mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
BC World Pharmaceutical Co., Ltd.
Telmisartan 80mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
BC World Healthcare Co., Ltd.
Telmisartan 40mg · S-Amlodipine Besylate Dihydrate 7.38mg
Tablet · Prescription medication · Combination
BC World Pharmaceutical Co., Ltd.
Telmisartan 40mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
BC World Pharma Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.